WASHINGTON, DC (October 28, 2026) – Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S ...
BIO Comment Letter – FDA-2025-N-6075 – Drug Establishment Registration and Drug Listing Requirements
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.
BIO's PACE draws record number of patient advocates. Plus: Proposed COINS Act rule adds to biotech regulation. (1,020 words, 4 minutes, 5 seconds) PACE: BIO convenes record number of patient advocates ...
OncoSynergy is a clinical stage immuno-oncology therapeutics company pioneering a breakthrough approach to significantly improving outcomes for patients suffering from the worst cancers. Our ...
BIO Partnering™ returns to the San Francisco Marriott Marquis for JPM Week 2027 with enhanced tools to help you identify the right partners, schedule meetings efficiently, and make the most of one of ...
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the proposed Outbound Investment Security Program (OISP) ...
WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical ...
BIO President & CEO John F. Crowley announced today that BIO would take several important steps to reaffirm the organization’s position with regards to national security and the role that the industry ...
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of ...
LaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor access program designed for established, ...
The United States International Trade Commission (USITC) today released its “COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities” report. The report aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results